Bristol Myers Squibb to Participate in Upcoming Investor Conferences
March 06 2024 - 4:17PM
Business Wire
Bristol Myers Squibb (NYSE: BMY) today announced that the
company will participate in two upcoming investor conferences in
March 2024.
Samit Hirawat, M.D., executive vice president, chief medical
officer, Drug Development, will take part in a fireside chat at the
Leerink Partners Global Biopharma Conference 2024 in Miami Beach,
Florida, on Wednesday, March 13, 2024. He will answer questions
about the company beginning at 10:00 a.m. ET.
Lynelle Hoch, president, Cell Therapy Organization, and Wendy
Short Bartie, senior vice president, U.S. Hematology and Oncology,
will participate in a fireside chat at the Barclays 26th Annual
Global Healthcare Conference in Miami Beach, Florida, on Thursday,
March 14, 2024. They will answer questions about the company
beginning at 8:30 a.m. ET.
Investors and the general public are invited to listen to both
sessions at their respective times by visiting
http://investor.bms.com. An archived edition of each session will
be available following its conclusion.
About Bristol Myers Squibb Company
Bristol Myers Squibb is a global biopharmaceutical company whose
mission is to discover, develop, and deliver innovative medicines
that help patients prevail over serious diseases. For more
information about Bristol Myers Squibb, visit us at BMS.com or
follow us on LinkedIn, Twitter, YouTube, Facebook, and
Instagram.
corporatefinancial-news
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240306806082/en/
Media: media@bms.com Investors:
investor.relations@bms.com
Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From Apr 2023 to Apr 2024